Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
Biogen
Age
18–65
Sex
ALL
Healthy volunteers
Not accepted
You may be eligible if
The candidate is a DMF-naïve patient
Have a diagnosis of relapsing forms of MS and satisfy the approved therapeutic indication for DMF
Have a recent (i.e., within the previous 6 months) complete blood count with results that do not preclude the patient's participation in the study, in the judgment of the Investigator
You may not be if
Have comorbid conditions that preclude participation in the study, as determined by the Investigator
History of severe allergic or anaphylactic reactions or known drug hypersensitivity
Are participating, planning to participate, or have participated in the Tecfidera QuickStart Program
Clareo Health | Study to Evaluate Whether a Medication Event Monitoring System (MEMS) Can Improve Adherence to Tecfidera Treatment in Multiple Sclerosis Patients.
